{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Bell RM"],"funding":["Singapore Ministry of Health’s National Medical Research Council","British Heart Foundation","Rosetrees Trust","Deutsche Forschungsgemeinschaft","National Institute for Health Research (NIHR)","National Research Foundation Singapore","PGC","Duke-NUS Signature Research Programme"],"pagination":["39"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9377667"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["117(1)"],"pubmed_abstract":["The Hatter Cardiovascular Institute biennial workshop, originally scheduled for April 2020 but postponed for 2 years due to the Covid pandemic, was organised to debate and discuss the future of Remote Ischaemic Conditioning (RIC). This evolved from the large multicentre CONDI-2-ERIC-PPCI outcome study which demonstrated no additional benefit when using RIC in the setting of ST-elevation myocardial infarction (STEMI). The workshop discussed how conditioning has led to a significant and fundamental understanding of the mechanisms preventing cell death following ischaemia and reperfusion, and the key target cyto-protective pathways recruited by protective interventions, such as RIC. However, the obvious need to translate this protection to the clinical setting has not materialised largely due"],"journal":["Basic research in cardiology"],"pubmed_title":["Remote ischaemic conditioning: defining critical criteria for success-report from the 11th Hatter Cardiovascular Workshop."],"pmcid":["PMC9377667"],"funding_grant_id":["FS/18/80/33937","M565","NMRC CG21APR1006","-","MOH-STaR21jun-0003","CRC 1116 B8","FS/CRTF/21/24251","PG/21/10798","2018-094025-B-I00","MCIN/AEI/10.13039/501100011033","NIHR128240","PG/19/51/34493","PG/18/10/33550","NMRC/CG21APRC006"],"pubmed_authors":["Bell RM","Hausenloy DJ","Ibanez B","Ntsekhe M","England TJ","Yellon DM","Cunningham J","Walker JM","Lecour S","Beikoghli Kalkhoran S","Davidson SM","Basalay M","Ghosh AK","Kleinbongard P","Giesz S","Lukhna K","Ovize M","Heusch G","Vilahur G","Carr RD","Golforoush P","Botker HE","Gourine AV","Salama AD"],"additional_accession":[]},"is_claimable":false,"name":"Remote ischaemic conditioning: defining critical criteria for success-report from the 11th Hatter Cardiovascular Workshop.","description":"The Hatter Cardiovascular Institute biennial workshop, originally scheduled for April 2020 but postponed for 2 years due to the Covid pandemic, was organised to debate and discuss the future of Remote Ischaemic Conditioning (RIC). This evolved from the large multicentre CONDI-2-ERIC-PPCI outcome study which demonstrated no additional benefit when using RIC in the setting of ST-elevation myocardial infarction (STEMI). The workshop discussed how conditioning has led to a significant and fundamental understanding of the mechanisms preventing cell death following ischaemia and reperfusion, and the key target cyto-protective pathways recruited by protective interventions, such as RIC. However, the obvious need to translate this protection to the clinical setting has not materialised largely due","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Aug","modification":"2025-05-29T14:36:46.506Z","creation":"2024-12-03T16:23:05.382Z"},"accession":"S-EPMC9377667","cross_references":{"pubmed":["35970954"],"doi":["10.1007/s00395-022-00947-2"]}}